Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002
Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
Predictors of sputum eosinophilia in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020
Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Persistent sputum eosinophilia in patients with difficult-to-treat asthma Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Monitoring of sputum eosinophils in long-term treatment of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005
Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Induced sputum IL-13 concentration in asthma, COPD and eosinophilic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Source: Eur Respir J 2007; 30: 472-478 Year: 2007
Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Eosinophilic inflammation in sputum of poorly controlled asthmatics Source: Eur Respir J 2002; 20: 1370-1377 Year: 2002
A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008